Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

(R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate

EU orphan designation number: EU/3/04/218
Active ingredient: (R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate
Indication: Treatment of renal cell carcinoma
Sponsor: Innate Pharma SAS
Grand Pré, 119/121 Ancien chemin de Cassis, 13009 Marseille, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/08/2004 Orphan designation EMEA/OD/030/04 (2004)2996 of 29/07/2004
20/03/2006 Change of name and/or address of sponsor
26/08/2010 Removal of orphan designation from Community Register